(Q53404726)
Statements
Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells. (English)
Thiesing JT
Ohno-Jones S
Kolibaba KS
Druker BJ
1 November 2000
96
9
3195-3199